MONDAY, Nov. 7, 2022 (HealthDay News) — While melanoma remains the most deadly type of skin cancer, new research has found that a subset of patients with early disease are at very low risk of dying. These particular patients may not face the same prognosis that is typically associated withContinue Reading

FRIDAY, Nov. 4, 2022 (HealthDay News) — The world desperately needs new antibiotics to fight infection as bacteria become resistant to existing options. GSK has developed a new antibiotic to treat urinary tract infections (UTIs) that appears to be so effective the pharmaceutical company stopped testing early on the recommendationContinue Reading